BEAMSTART Logo

HomeNews

Parliament panel asks single independent drug regulator for Ayush medicines

Business Standard LogoBusiness Standard7h ago

Parliament panel asks single independent drug regulator for Ayush medicines - Business Standard

Quick Summary:

To achieve this, the ministry should establish a streamlined and inclusive mechanism that actively involves stakeholders in the development of pharmacopoeial standards, ensuring greater efficiency and uniformity, said the Parliamentary Standing Committee on Health and Family Welfare in a report presented in the Rajya Sabha this week.

Additionally, the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) and Central Council for Research in Ayurvedic Sciences (CCRAS) may come together to coordinate and collaborate in this initiative, the committee emphasised in its 165th report on "Demands for Grants 2025-26 (Demand No.4) of Ministry of Ayush".

A parliamentary committee has recommended the consolidation of all AYUSH drug-related standard-setting processes under a single independent drug controller in alignment with the Drugs and Cosmetics Act, 1940, and its associated rules.


More Pictures

Parliament panel asks single independent drug regulator for Ayush medicines - Business Standard (Picture 1)

or

Article Details

Category: BusinessFinance

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-03-16 @ 16:59:43 (7 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 783 words

Reading Time: 5 minutes read

Sentences: 22 lines

Sentence Length: 36 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 27052034

View Article Analysis

About Business Standard

Business Standard Logo

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 111 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 3 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Parliament panel asks single independent drug regulator for Ayush medicines" has 783 words across 22 sentences, which will take approximately 4 - 7 minutes for the average person to read.

Which news outlet covered this story?

The story "Parliament panel asks single independent drug regulator for Ayush medicines" was covered 7 hours ago by Business Standard, a news publisher based in India.

How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news.

The outlet is headquartered in India and publishes an average of 111 news stories per day.

It's most recent story was published 3 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #27052034
  • URL: https://beamstart.com/news/parliament-panel-asks-single-independent-174212540

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.